88 patents
Page 4 of 5
Utility
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
30 Mar 21
Controlled release dosage forms are described herein.
Clark Allphin, James Pfeiffer
Filed: 4 Sep 20
Utility
Methods and compositions for treating excessive sleepiness
30 Mar 21
The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
Lawrence Patrick Carter, Yuan Lu, Katayoun Zomorodi
Filed: 1 Jun 18
Utility
Treatment for Obesity
18 Mar 21
The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
Moise A. Khayrallah, Gary Bream, Stephen E. Butts
Filed: 22 Sep 20
Utility
Methods of providing solriamfetol therapy to subjects with impaired renal function
9 Mar 21
The invention relates to methods for decreasing adverse effects associated with solriamfetol ([R]-2-amino-3-phenylpropylcarbamate) therapy in subjects with impaired renal function.
Katayoun Zomorodi
Filed: 19 Mar 20
Utility
Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
25 Feb 21
The present invention relates to a newly identified solvate form of (R)-2-amino-3-phenylpropyl carbamate (APC) hydrochloride, a method of preparing APC hydrochloride, and methods of using the same to treat disorders.
Fionn Hurley
Filed: 6 Nov 20
Utility
Defibrotide for Use In Prophylaxis And/or Treatment of Graft Versus Host Disease (GVHD)
25 Feb 21
Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD) in humans is disclosed, preferably in hematopoietic stem cell transplantation (HSCT), more preferably allogeneic hematopoietic stem cell transplantation.
Massimo IACOBELLI
Filed: 29 Jul 20
Utility
Methods and compositions for treating excessive sleepiness
9 Feb 21
The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
Lawrence Patrick Carter, Yuan Lu, Katayoun Zomorodi
Filed: 19 May 20
Utility
Sensitive Drug Distribution Systems and Methods
21 Jan 21
A drug distribution system and method utilizes a central pharmacy and database to track all prescriptions for a sensitive drug.
Prasheel Vashdev Lillaney, Sherice ReneƩ Mills, Gary Joseph Appio
Filed: 2 Oct 20
Utility
Controlled Release Dosage Forms for High Dose, Water Soluble and Hygroscopic Drug Substances
23 Dec 20
Controlled release dosage forms are described herein.
Clark ALLPHIN, James PFEIFFER
Filed: 3 Sep 20
Utility
Controlled Release Dosage Forms for High Dose, Water Soluble and Hygroscopic Drug Substances
23 Dec 20
Controlled release dosage forms are described herein.
Clark ALLPHIN, James PFEIFFER
Filed: 3 Sep 20
Utility
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
14 Dec 20
One embodiment of the present invention is to improve the safety and efficacy of the administration of GHB or a salt thereof to a patient.
Mark Eller
Filed: 9 Jan 19
Utility
Solvate form of (R)-2-amino-3-phenylpropyl carbamate
9 Nov 20
The present invention relates to a newly identified solvate form of (i?)-2-amino-3-phenylpropyl carbamate (APC) hydrochloride, a method of preparing APC hydrochloride, and methods of using the same to treat disorders.
Jennifer Leigh Nelson, Fionn Hurley
Filed: 5 Sep 17
Utility
Gamma-hydroxybutyrate Compositions and Their Uses for the Treatment of Disorders
28 Oct 20
Provided herein are pharmaceutical compositions and formulations comprising mixed salts of gamma-hydroxybutyrate (GHB).
Clark P. Allphin, Michael DesJardin
Filed: 11 May 20
Utility
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
26 Oct 20
Controlled release dosage forms are described herein.
Clark Allphin, James Pfeiffer
Filed: 29 Jun 20
Utility
Alcohol-resistant Drug Formulations
21 Oct 20
The invention relates to modified release oral formulations of therapeutic agents, including gamma hydroxybutyrate (GHB), paracetamol, codeine or oxycodone, which are resistant to alcohol induced dose dumping.
Edwin WALSH, Clark Patrick ALLPHIN
Filed: 18 Nov 19
Utility
Controlled Release Dosage Forms for High Dose, Water Soluble and Hygroscopic Drug Substances
21 Oct 20
Controlled release dosage forms are described herein.
Clark ALLPHIN, James PFEIFFER
Filed: 29 Jun 20
Utility
Carbamoyl Phenylalaninol Compounds and Uses Thereof
16 Sep 20
The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
Fionn Hurley, Lawrence Patrick Carter
Filed: 2 Jun 20
Utility
Methods and Compositions for Treating Excessive Sleepiness
9 Sep 20
The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.
Lawrence Patrick Carter, Yuan Lu
Filed: 18 May 20
Utility
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
31 Aug 20
Controlled release dosage forms are described herein.
Clark Allphin, James Pfeiffer
Filed: 1 Jul 18
Utility
High Concentration Formulations
19 Aug 20
Low-viscosity, high concentration nucleic acid compositions that can be administered by multiple parenteral routes may allow for less frequent dosing than nucleic acid products currently on the market.
Mariana Dimitrova, William J. Bennett, Qi Wang
Filed: 19 Aug 18